# Efficacy of the Brand-name Latanoprost and One of Its Generic Version in Primary Open Angle Glaucoma and Ocular Hypertension

> **NCT02047630** · PHASE4 · TERMINATED · sponsor: **CHU de Quebec-Universite Laval** · enrollment: 60 (estimated)

## Conditions studied

- Primary Open Angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Generic latanoprost
- **DRUG:** Brand-name latanoprost

## Key facts

- **NCT ID:** NCT02047630
- **Lead sponsor:** CHU de Quebec-Universite Laval
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-01
- **Primary completion:** 2014-12-04
- **Final completion:** 2014-12-04
- **Target enrollment:** 60 (ESTIMATED)
- **Why stopped:** Problem with IP supply
- **Last updated:** 2017-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02047630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02047630, "Efficacy of the Brand-name Latanoprost and One of Its Generic Version in Primary Open Angle Glaucoma and Ocular Hypertension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02047630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*